Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate

M. Mokhtarani, G. A. Diaz, U. Lichter-Konecki, S. A. Berry, J. Bartley, S. E. McCandless, W. Smith, C. Harding, C. Le Mons, D. F. Coakley, B. Lee, B. F. Scharschmidt

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)12-14
Number of pages3
JournalMolecular Genetics and Metabolism Reports
Volume5
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Molecular Biology
  • Genetics
  • Endocrinology

Keywords

  • Biomarker
  • Glycerol phenylbutyrate
  • Phenylacetate
  • Phenylbutyrate
  • Urea cycle disorder
  • Urinary phenylacetylglutamine

Cite this